echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Natural Products News > PLoS Biol: dead cells destroy immune cells' response to wounds

    PLoS Biol: dead cells destroy immune cells' response to wounds

    • Last Update: 2019-05-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    May 28, 2019 / BIOON / - a new study found that dead cells can damage the immune response and the immune system's defense against infection The study, led by scientists at the University of Sheffield, shows that programmed dead cells, known as apoptosis, can disrupt the normal function of immune cells called macrophages This may affect their response to wounds and body visits to detect infection Photo source: macrophages are needed at the wound site of PLoS Biology to prevent infection and help heal, but these leukocytes can also cause and worsen many human diseases, including cancer, heart disease and neurodegenerative diseases The results, published in the journal PLoS Biology, show that immune cells preferentially remove dead cells, which can hinder their normal migration to the wound site, thereby weakening the immune response The study aims to understand how immune cells are controlled and may help pave the way for new therapies that manipulate these cells and accelerate healing This research gives scientists a new understanding of the mechanisms that control our immune cells, such as how they reach and store in the injured area Dr iwan Evans, of the Department of infection, immunology and cardiovascular disease at the University of Sheffield, who is one of the authors of the paper, said: "if the clearance process goes wrong, it can lead to autoimmune diseases Excessive or inappropriate immune responses can worsen or lead to a wide range of human diseases, from cancer to neurodegenerative diseases This work is about the basic biological process Our body is doing it every day, which is necessary for us to keep healthy "The purpose of this study is to study the interaction between dead cells and immune cells The flies used contain macrophage like cells, which are highly similar to our own immune cells The new study also found a protein called six microns under (or SIMU) that keeps immune cells at the site of injury Without this protein, macrophages would leave the wound prematurely Hannah Roddie, the study's author and research assistant for the infection, immune and cardiovascular disease program at the University of Sheffield, said: "research shows that Drosophila's blood cells respond to injury and death in a way more similar to our own immune cells than we think We are now looking at the signals macrophages use to track dead cells and how they choose between dead cells and wounds We'd like to know how immune cells stay in the injured area (bio Com) reference: Hannah grace Roddie et al Simul dependent clearance of dying cells regulations macrophase function and information resolution, PLoS Biology (2019) Doi: 10.1371/journal.pbio.2006741
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.